Related Experiment Video
Updated: Jul 8, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Specific information about the WHO guidelines for gestational diabetes screening improves clinical practices
Angèle Gayet-Ageron1, Bénédicte Poncet, Pascale Guerre
1Pôle Information médicale Evaluation Recherche, Hospices Civils de Lyon, and Université Lyon 1, Lyon, France.
Providing specific information on World Health Organization (WHO) gestational diabetes mellitus (GDM) screening guidelines significantly improved clinical practices. The GDM screening test demonstrated high acceptance rates among pregnant women.
Area of Science:
- Obstetrics and Gynecology
- Public Health
- Endocrinology
Background:
- Gestational diabetes mellitus (GDM) poses risks to both mother and fetus.
- Standardized screening protocols are crucial for early detection and management.
- The World Health Organization (WHO) provides guidelines for GDM screening.
Purpose of the Study:
- To assess the effect of targeted information on WHO GDM screening guidelines on clinical practices.
- To evaluate pregnant women's acceptance of GDM screening.
Main Methods:
- A non-randomized interventional study design comparing two periods (before and after guideline implementation).
- Implementation involved reminders, meetings, and pre-printed prescription sheets.
- Women were interviewed to gauge their acceptance of GDM screening.
Main Results:
- Screening rates increased dramatically from 0.9% to 59.1% post-implementation (P < 10(-3)).
- 80% of screenings in the post-implementation period adhered to WHO guidelines.
- Test acceptability was high at 98%, with 90% willing to be screened again.
Conclusions:
- Disseminating WHO GDM screening guidelines effectively enhances physician adherence to best practices.
- High patient acceptance supports broader implementation of WHO GDM screening protocols during pregnancy.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes: Symptoms, Diagnosis, and Complications
Hyperglycemia
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
